EE9800176A - Koostis organite külmsäilitamiseks ning viirus- ja bakterinfektsioonide ravimiseks - Google Patents

Koostis organite külmsäilitamiseks ning viirus- ja bakterinfektsioonide ravimiseks

Info

Publication number
EE9800176A
EE9800176A EE9800176A EE9800176A EE9800176A EE 9800176 A EE9800176 A EE 9800176A EE 9800176 A EE9800176 A EE 9800176A EE 9800176 A EE9800176 A EE 9800176A EE 9800176 A EE9800176 A EE 9800176A
Authority
EE
Estonia
Prior art keywords
viral
organs
treatment
composition
cold storage
Prior art date
Application number
EE9800176A
Other languages
English (en)
Inventor
Olga Patricia Giesteira Visser Michelle
Original Assignee
Cryopreservation Technologies Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryopreservation Technologies Cc filed Critical Cryopreservation Technologies Cc
Publication of EE9800176A publication Critical patent/EE9800176A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9800176A 1995-12-15 1996-12-13 Koostis organite külmsäilitamiseks ning viirus- ja bakterinfektsioonide ravimiseks EE9800176A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA9510674 1995-12-15
ZA965755 1996-07-05
PCT/US1996/019697 WO1997022248A1 (en) 1995-12-15 1996-12-13 Composition for organ cryopreservation and treatment of viral and bacterial infections

Publications (1)

Publication Number Publication Date
EE9800176A true EE9800176A (et) 1998-12-15

Family

ID=59812115

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800176A EE9800176A (et) 1995-12-15 1996-12-13 Koostis organite külmsäilitamiseks ning viirus- ja bakterinfektsioonide ravimiseks

Country Status (25)

Country Link
US (1) US5935597A (et)
EP (1) EP0966196A4 (et)
JP (1) JP2000515115A (et)
KR (1) KR20000064396A (et)
AP (1) AP9801258A0 (et)
AU (1) AU724026B2 (et)
BG (1) BG102528A (et)
BR (1) BR9612004A (et)
CA (1) CA2240131A1 (et)
CZ (1) CZ182098A3 (et)
EA (1) EA001957B1 (et)
EE (1) EE9800176A (et)
GE (1) GEP20012423B (et)
IL (1) IL124733A0 (et)
IS (1) IS4763A (et)
LV (1) LV12172B (et)
MX (1) MX9804826A (et)
NO (1) NO982653L (et)
NZ (2) NZ501172A (et)
OA (1) OA10695A (et)
PL (1) PL327199A1 (et)
SI (1) SI9620126A (et)
SK (1) SK79998A3 (et)
TR (1) TR199801066T2 (et)
WO (1) WO1997022248A1 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA984649B (en) * 1997-06-13 1999-12-17 Cryopreservation Tech Cc "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes".
KR100269312B1 (ko) * 1997-10-14 2000-10-16 윤종용 실리콘막의결정화방법및이를이용한박막트랜지스터-액정표시장치(tft-lcd)의제조방법
HUP0302631A2 (hu) 2000-03-30 2003-11-28 Bristol-Myers Squibb Co. Stavudint tartalmazó elnyújtott hatóanyag-kibocsátású szemcsék
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
CA2324631A1 (en) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited A substance or composition for the treatment of cancer
SE522979C2 (sv) * 2002-07-03 2004-03-23 Moelnlycke Health Care Ab Sårförband innefattande en icke-enzymatisk antioxidant
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
US20100137635A1 (en) * 2005-06-07 2010-06-03 Inbiotex Inc. Radical scavenger and active oxygen eliminating agent
EP2606895A4 (en) * 2010-10-12 2014-04-02 Univ Wuhan TRANSDERMAL ABSORPTION STAMP OF ANTIVIRAL DRUG AND METHOD FOR PREPARING THE SAME
US11103460B2 (en) 2017-08-07 2021-08-31 Board Of Regents, The University Of Texas System Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1119689A1 (ru) * 1982-07-28 1984-10-23 Всесоюзный Научно-Исследовательский Институт Разведения И Генетики Сельскохозяйственных Животных Способ обработки спермы
FR2546755B1 (fr) * 1983-06-01 1986-04-25 Galoubet Jf Pellegrin Cie Ecur Procede pour la conservation de sperme notamment des chevaux
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
AT391809B (de) * 1988-01-12 1990-12-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutplasmaprodukten
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5217860A (en) * 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification
KR100275843B1 (ko) * 1992-02-20 2000-12-15 슈테펜엘.네스비트 설폰산 유도체 및 이를 포함하는 약제학적 조성물

Also Published As

Publication number Publication date
WO1997022248A1 (en) 1997-06-26
LV12172A (lv) 1998-12-20
NZ501172A (en) 2000-04-28
SI9620126A (sl) 1999-10-31
JP2000515115A (ja) 2000-11-14
MX9804826A (es) 1998-10-31
EA001957B1 (ru) 2001-10-22
NO982653L (no) 1998-08-17
BR9612004A (pt) 1999-12-28
US5935597A (en) 1999-08-10
CA2240131A1 (en) 1997-06-26
AU1684897A (en) 1997-07-14
NO982653D0 (no) 1998-06-09
KR20000064396A (ko) 2000-11-06
EP0966196A1 (en) 1999-12-29
IS4763A (is) 1998-06-03
EA199800558A1 (ru) 1998-12-24
AU724026B2 (en) 2000-09-07
PL327199A1 (en) 1998-11-23
IL124733A0 (en) 1999-01-26
TR199801066T2 (xx) 1998-08-21
SK79998A3 (en) 1999-02-11
OA10695A (en) 2002-11-27
EP0966196A4 (en) 2002-03-27
GEP20012423B (en) 2001-05-25
BG102528A (bg) 1999-08-31
NZ330642A (en) 2000-06-23
CZ182098A3 (cs) 1998-11-11
LV12172B (en) 1999-04-20
AP9801258A0 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
NO20012978L (no) Fremgangsmåte og preparater for behandling av alvorlig bronkitt med et aerosolisert antibiotikum
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
AU2500097A (en) Compositions containing bacteriophages and methods of using bacteriophages to treat infections
EP2270046A3 (en) Methods and compositions for the treatment of hemolysis-associated diseases
DE69739583D1 (de) Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
DE69524365D1 (de) Verfahren zur Isolierung und Reinigung von 2&#39;-Deoxy-2&#39;,2&#39;-difluornucleosiden
AU2531697A (en) Fermi-threshold field effect transistors including source/drain pocket implants and methods of fabricating same
AU2296995A (en) Composition and method for treatment of cmv infection
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
IL118091A0 (en) Formulations for use in treating pediatric bacterial infections
EE9800176A (et) Koostis organite külmsäilitamiseks ning viirus- ja bakterinfektsioonide ravimiseks
EP0975654A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTIONS
ID21948A (id) Penggunaan 1-hidroksi-2piridon untuk pengobatan infeksi-infeksi kulit
NO940810D0 (no) Behandling av virusinfeksjoner
GB9811347D0 (en) Improvements in or relating diagnosis and treatment of bacterial infections
AUPN907296A0 (en) Biocontrol agents for use in treatment of opportunistic infections
NO982562D0 (no) Sammensetning for behandling av smerte
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
LT98090A (en) Composition for organ cryopreservation and treatment of viral and bacterial infections
NO975683L (no) Fremgangsmåte for inaktivering av virus- og bakterielle-blodkontaminanter
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
HUP0001161A3 (en) Composition for organ cryopreservation and treatment of viral and bacterial infections
FR2705362B1 (fr) Clônage et expression du gêne de l&#39;enzyme malolactique de Lactococcus lactis.
HUP9802450A3 (en) Use of prostane derivatives and the combination thereof for preparing pharmaceutical compositions for use in treatment of bacterial infections